Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide Dose Comparison in Relapsed Multiple Myeloma
NCT01380106Phase 2Completed
- Sponsor
- Boston VA Research Institute
- Start
- Aug 2010
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Boston VA Research Institute. Started Aug 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01380106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380106.